News
Tempus AI (TEM) stock is tanking following a short seller report that raised concerns about the company, its products, and ...
Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
AstraZeneca easily delivered on chief executive Pascal Soriot’s pledge to deliver $45 billion in revenues by 2023, set a decade earlier as he fended off a takeover bid by Pfizer. Now, he thinks ...
AstraZeneca has teamed up with DNA sequencing giant Illumina on a new programme that will use artificial intelligence to find new targets for drug discovery by sifting through vast arrays of data ...
Opinion
Howard Levitt: Think the issue of workplace vaccine mandates is long-settled? Not quite, say courtsThere must be a sufficient connection between a worker's responsibilities and the vaccination requirement to justify imposing 'the ultimate penalty' ...
David Wong, Chief Product Officer and Ryan Kessler, Head of Finance, Legal Professionals at Thomson Reuters (TSX/Nasdaq: TRI) will both present at CIBC Technology & Innovation Conference on ...
Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results